ArticleNeuro-oncology2012

A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054).

Roy Rampling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.